ArticleNeoplasia (New York, N.Y.)2020

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment.

Steven Kregel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.